Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. The company, founded in 2005 and headquartered in the United States, specializes in providing contract biologic R&D and manufacturing services to diagnostic manufacturers, as well as GMP biologics manufacturing for the biopharmaceutical market. Furthermore, Creative Diagnostics offers support for rapidly developing, manufacturing, and commercializing point-of-care lateral flow, flow-through, and ELISA assays across various market segments. The company leverages fluorescent, visual colloidal gold, and paramagnetic labels, with a focus on high sensitivity, quantitative, and reader-based tests. With a strong emphasis on Biotechnology, Health Care, and Manufacturing industries, Creative Diagnostics prides itself on its commitment to delivering the highest quality products and services to its customers in both research and industry sectors. As of now, there is no publicly available information about the company's recent investment activities or investors.